India Prevenar 13 Patent Challenge Closely Watched As Test Case

Ruling could come as early as next month in international humanitarian group MSF’s challenge to Pfizer's application for Indian patent on its blockbuster pneumococcal vaccine; observers see ruling as test of whether India is sticking to its stringent patent policy in face of growing pressure from foreign pharmaceutical companies.